Treatment characteristics and safety profiles of Belbuca®, buprenorphine patch, and oral schedule II opioids among chronic low back pain patients without a positive history of opioid-use disorder: a retrospective US commercial claims analysis.

Zah V et al.

NCBI PubMed Central · Papers · License: Open Access

behavioral economics

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 371563
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.